Logo
csv. check, some, votes

Objection pursuant to Rule 112: Extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (D061354)

Reference: B9-0103/2019

Date: 10.10.2019

Previous
Next

Non-attached Members (NI)

57 Members

Group Voting Result
Total: 57 MEPs
21 For
2 Against
25 Abstention
9 Did not vote
21 For
2 Against
25 Abstention
9 Did not vote
Group Members
← Back to Vote